At the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria, Dr Janet Wilson from Leeds Teaching Hospital, UK, presented data from ...

At ESCMID Global, Microbix will be showcasing its QAPs innovations for helping to ensure the accuracy of diagnostic tests, including for bacterial, viral, and parasitic diseases, and in multiple ...

Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program ResultsMISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a ...

A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups ...

At the ESCMID Global conference (www.eccmid.org), Bruker announced a significant menu expansion of its validated PCR assays on its BeGenius ® sample-to-answer molecular diagnostics system, as well as ...

MISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and ...

Microbix Exhibiting at ESCMID Global 2025 Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program Results. MISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) ...

ESCMID Global is the Congress of the European Society of Clinical Microbiology and Infectious Diseases, taking place in Vienna, Austria April 11-15, 2025.

MISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, announces that it ...